Unilife (UNIS) Soars on Multi Million Dollar Supply Contract,

Shares of Unilife Corporation (UNIS) jumped $1.23 (or +43.93%) to $4.03 on Wednesday's trading session, after the company reported the signing of a long-term commercial supply contract with Hikma Pharmaceuticals PLC for the use of Unifill(R) prefilled syringes with a range of generic injectable-drugs.

Under the 15-year contract, UNIS will supply Hikma with customized prefillable delivery systems from its Unifill(R) platform, including the Unifill syringe and the Unifill Nexus

Hikma will pay UNIS for product sales and $40 million in upfront and milestone payments. An initial payment of $5 million will be made to UNIS immediately, with additional $15 million in payments during 2014.

Market demand for generic injectables is rapidly shifting from vials to prefilled syringes. However, conventional prefilled devices prevent universal attachment with any ISO standard needle hub or IV connector and are also associated with patient safety risks, including spontaneous disconnection and the leakage or occlusion of medication.

The superior design of UNIS ' Unifill Nexus addresses these issues and is expected to rapidly become the preferred choice to deliver generic injectable-drugs.

UNIS is a U.S. based developer and commercial supplier of injectable-drug delivery systems. UNIS ' broad portfolio includes prefilled syringes with automatic needle retraction, drug-reconstitution delivery systems, auto-injectors, wearable injectors, intraocular delivery systems and novel devices.

More about Unilife Corporation (UNIS) at www.unilife.com

**

According to eMarketer, online retail sales will grow from $225.5 billion in 2012, to $434.2 billion in 2017.

According to comScore Data, in September 2013, 188.7 million Americans watched 46 billion online content videos in September, while the number of video ad views totaled 22.9 billion.

Crown Equity Holdings Inc. (CRWE) is looking to deliver value for its stockholders in both the near and long term, refocusing its strategic plan to improve the potential future growth for the company, targeting the multi-billion dollar online video-sharing and online b2b markets, with its Division CRWETube ( www.crwetube.com ) and its iB2B Global project, respectively.

As a worldwide online multi-media publisher, CRWE ‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. CRWE launches, invests and manages select businesses, projects and real estate endeavors.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .

**

The price of La-Z-Boy Incorporated (LZB) stock surged $2.40 (or +9.83%) to $26.82 per share, after the company reported strong performance on its operating results,

On its second quarter fiscal 2014, LZB posted consolidated sales of $366.40 million, a 13.7% increase year over year, and net income attributable to LZB of $16.7 million, or $0.31 per diluted share, of which $0.01 per share was attributable to the reduction of certain valuation reserves against the company's state deferred tax assets, compared with $6.6 million, or $0.12 per diluted share, after $0.03 in restructuring charges relating to the company's casegoods segment, in the same period the prior year..

During the quarter, LZB generated cash from operating activities of $19.4 million.

LZB is one of the world's leading residential furniture producers, marketing furniture for every room of the home.

More about La-Z-Boy Incorporated (LZB) at www.la-z-boy.com

**

Shares of Layne Christensen Company (LAYN) closed at $16.22, up $0.05 (or +0.31%). The company was upgraded from Sell to Neutral and price target of $16.00 by brokerage firm UBS.

LAYN is a global water management, construction and drilling company, providing responsible solutions to the world of essential natural resources — water, mineral and energy.

More about Layne Christensen Company (LAYN) at www.layne.com

**

Read Full Disclaimer at www.pennyomega.com/disclaimer